10-104037620-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000494.4(COL17A1):c.3208+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.807 in 1,613,628 control chromosomes in the GnomAD database, including 531,264 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.72 ( 41630 hom., cov: 32)
Exomes 𝑓: 0.82 ( 489634 hom. )
Consequence
COL17A1
NM_000494.4 intron
NM_000494.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.972
Publications
11 publications found
Genes affected
COL17A1 (HGNC:2194): (collagen type XVII alpha 1 chain) This gene encodes the alpha chain of type XVII collagen. Unlike most collagens, collagen XVII is a transmembrane protein. Collagen XVII is a structural component of hemidesmosomes, multiprotein complexes at the dermal-epidermal basement membrane zone that mediate adhesion of keratinocytes to the underlying membrane. Mutations in this gene are associated with both generalized atrophic benign and junctional epidermolysis bullosa. Two homotrimeric forms of type XVII collagen exist. The full length form is the transmembrane protein. A soluble form, referred to as either ectodomain or LAD-1, is generated by proteolytic processing of the full length form. [provided by RefSeq, Jul 2008]
COL17A1 Gene-Disease associations (from GenCC):
- epithelial recurrent erosion dystrophyInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
- epidermolysis bullosa, junctional 4, intermediateInheritance: AR Classification: DEFINITIVE Submitted by: G2P, Ambry Genetics
- junctional epidermolysis bullosa, non-Herlitz typeInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- amelogenesis imperfectaInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- generalized junctional epidermolysis bullosa non-Herlitz typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- late-onset junctional epidermolysis bullosaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- localized junctional epidermolysis bullosa, non-Herlitz typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 10-104037620-G-A is Benign according to our data. Variant chr10-104037620-G-A is described in ClinVar as [Benign]. Clinvar id is 256272.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.827 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.724 AC: 110057AN: 151974Hom.: 41637 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
110057
AN:
151974
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.784 AC: 197028AN: 251384 AF XY: 0.786 show subpopulations
GnomAD2 exomes
AF:
AC:
197028
AN:
251384
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.816 AC: 1192267AN: 1461536Hom.: 489634 Cov.: 51 AF XY: 0.814 AC XY: 591564AN XY: 727074 show subpopulations
GnomAD4 exome
AF:
AC:
1192267
AN:
1461536
Hom.:
Cov.:
51
AF XY:
AC XY:
591564
AN XY:
727074
show subpopulations
African (AFR)
AF:
AC:
15555
AN:
33468
American (AMR)
AF:
AC:
35263
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
21356
AN:
26130
East Asian (EAS)
AF:
AC:
33294
AN:
39700
South Asian (SAS)
AF:
AC:
62403
AN:
86238
European-Finnish (FIN)
AF:
AC:
41249
AN:
53402
Middle Eastern (MID)
AF:
AC:
4427
AN:
5694
European-Non Finnish (NFE)
AF:
AC:
930658
AN:
1111814
Other (OTH)
AF:
AC:
48062
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
12033
24066
36098
48131
60164
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
21010
42020
63030
84040
105050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.724 AC: 110070AN: 152092Hom.: 41630 Cov.: 32 AF XY: 0.723 AC XY: 53781AN XY: 74344 show subpopulations
GnomAD4 genome
AF:
AC:
110070
AN:
152092
Hom.:
Cov.:
32
AF XY:
AC XY:
53781
AN XY:
74344
show subpopulations
African (AFR)
AF:
AC:
19958
AN:
41452
American (AMR)
AF:
AC:
12129
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
2880
AN:
3468
East Asian (EAS)
AF:
AC:
4334
AN:
5156
South Asian (SAS)
AF:
AC:
3393
AN:
4818
European-Finnish (FIN)
AF:
AC:
8152
AN:
10584
Middle Eastern (MID)
AF:
AC:
235
AN:
294
European-Non Finnish (NFE)
AF:
AC:
56615
AN:
68000
Other (OTH)
AF:
AC:
1574
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1369
2737
4106
5474
6843
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
826
1652
2478
3304
4130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2494
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Junctional epidermolysis bullosa, non-Herlitz type Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Epithelial recurrent erosion dystrophy Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.